Pfizer’s Q4 sales overshoot expectations - Pharma Times (subscription)
Pfizer’s Q4 sales overshoot expectations
Pharma Times (subscription), UK -
On the plus side, sales of Celebrex jumped 12% to $2.3 billion, Lyrica leapt 58% to $1.8 billion, cancer drug Sutent (sunitinib) jumped 166% to $581 million …
Leave a Reply
You must be logged in to post a comment.